Anti-serum albumin binding variants
AssigneeGlaxo Group Limited
InventorsElena De Angelis, Carolyn Enever, Haiqun Liu, Oliver Schon
Life of this patent
Estimating the term…
Abstract
The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-14, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
Claims6
A nucleic acid comprising a nucleotide sequence encoding an anti-serum albumin immunoglobulin single variable domain comprising the amino acid sequence of SEQ ID NO:
- 412 (DOM7h-14-10 R108C).
A nucleic acid comprising a nucleic acid comprising a nucleotide sequence encoding an anti-serum albumin immunoglobulin single variable domain, said nucleic acid comprising the nucleotide sequence of SEQ ID NO:
- 413 (DOM7h-14-10 R108C).
Dependencies are inferred from the claim text.